Dysregulated hematopoiesis and a progressive neurological disorder induced by expression of an activated form of the human common β chain in transgenic mice

Journal of Clinical Investigation

Volumn 102, Issue 11, 1998, Pages 1951-1960

  D'Andrea, Richard J ^a   Harrison Findik, Duygu ^a   Butcher, Carolyn M ^a   Finnie, John ^b   Blumbergs, Peter ^b   Bartley, Paul ^a   McCormack, Matthew ^a   Jones, Karen ^a   Rowland, Robert ^b   Gonda, Thomas J ^a   Vadas, Mathew A ^a  

^a HANSON INSTITUTE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Cytokine receptor; Granulocyte macrophage colony stimulating factor; Interleukin 3; Mutation; Polycythemia vera

Indexed keywords

CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA CHAIN; COLONY FORMATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; GENE MUTATION; HEMATOPOIESIS; LIGAND BINDING; MACROPHAGE ACTIVATION; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTO ONCOGENE; TRANSGENIC MOUSE;

EID: 0032407787     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3729     Document Type: Article

References (13)

1. Bagley, C.J., J.M. Woodcock, F.C. Stomski, and A.F. Lopez. 1997. The structural and functional basis of cytokine receptor activation: lessons from the common β subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) and IL-5 receptors. Blood. 89:1471-1482.
2. Miyajima, A., A.L. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood. 82:1960-1974.
3. Miyajima, A., T. Kiamura, N. Harada, T. Yokota, and K. Arai. 1992. Cytokine receptors and signal transduction. Ann. Rev. Immunol. 10:295-331.
4. Arai, K., F. Lee, A. Miyajima, S. Miyatake, N. Arai, and T. Yokota. 1990. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:783-836.
5. Schrader, J.W. 1986. The pan specific hemopoietin of activated T lymphocytes (interleukin-3). Ann. Rev. Immunol. 4:205-230.
6. Frendl, G., and D.I. Beller. 1990. Regulation of macrophage activation by IL-3. J. Immunol. 144:3392-3399.
7. Burgess, A.W., J. Camakaris, and D. Metcalf. 1977. Purification and properties of colony-stimulating factor from mouse lung conditioned medium. J. Biol. Chem. 252:1998-2006.
8. Metcalf, D., G.R. Burgess, G.R. Johnson, N.A. Nicola, E.C. Nice, J. DeLamarter, G.R. Thatcher, and J. Mermod. 1986. In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in E. coli comparison with purified native GM-CSF. J. Cell. Physiol. 128:421.
9. Burke, F., M.S. Naylor, B. Davies, and F. Balkwill. 1993. The cytokine wall chart. Immunol. Today. 14:165-169.
10. Vadas, M.A., and A.F. Lopez. 1984. Regulation of granulocyte function by colony stimulating factors. Lymphokine Res. 3:45-50.
11. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.D. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
12. Lopez, A.F., L.B. To, Y. Yang, J.R. Gamble, M.F. Shannon, G.F. Burns, P.C. Dyson, C.A. Juttner, S. Clark, and M.A. Vadas. 1987. Stimulation of proliferation, differentiation, and function of human cells by primate interleukin-3. Proc. Natl. Acad. Sci. USA. 84:2761-2765.
13. Sanderson, C.J. 1992. Interleukin-5, eosinophils and disease. Blood. 79: 3101-3109.